Mereo Biopharma Group Plc ADR (MREO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 0 | 500 | 0 | 0 | 0 |
| Cost of Goods | N/A | 132 | N/A | N/A | N/A |
| Gross Profit | N/A | 368 | N/A | N/A | N/A |
| Operating Expenses | 10,315 | 10,999 | 11,202 | 15,277 | 9,373 |
| Operating Income | -10,315 | -10,499 | -11,202 | -15,277 | -9,373 |
| Interest Expense | 28 | 24 | 180 | 376 | 353 |
| Other Income | 3,319 | -4,093 | -1,505 | 8,607 | -5,275 |
| Pre-tax Income | -7,024 | -14,616 | -12,887 | -7,046 | -15,001 |
| Net Income Continuous | -7,024 | -14,616 | -12,887 | -7,046 | -15,001 |
| Net Income | $-7,024 | $-14,616 | $-12,887 | $-7,046 | $-15,001 |
| EPS Basic Total Ops | -0.05 | -0.09 | -0.08 | -0.04 | -0.10 |
| EPS Basic Continuous Ops | -0.04 | -0.09 | -0.08 | -0.05 | -0.10 |
| EPS Diluted Total Ops | -0.05 | -0.09 | -0.08 | -0.04 | -0.10 |
| EPS Diluted Continuous Ops | -0.04 | -0.09 | -0.08 | -0.05 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 |
| EBITDA(a) | $-10,459 | $-10,337 | $-11,058 | $-15,129 | $-9,220 |